AYVAKYT
Identification of Ayvakyt
No description |
Google image searchProduct monograph
Active ingredient
avapritinib, 50 MG
DIN: 02551772
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: BLUEPRINT MEDICINES CORPORATION
Date: 02-DEC-2024
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
- L01EX18 — AVAPRITINIB (ATC/DDD)
Reference brand drug: Ayvakyt